Comments
Loading...

Bio-Rad Laboratories Analyst Ratings

BIONYSE
Logo brought to you by Benzinga Data
$232.00
1.540.67%
At close: -
$232.00
0.000.00%
After Hours: Jun 18, 4:00 PM EDT
Consensus Rating1
Outperform
Highest Price Target1
$550.00
Lowest Price Target1
$245.00
Consensus Price Target1
$383.86

Bio-Rad Laboratories Analyst Ratings and Price Targets | NYSE:BIO | Benzinga

Bio-Rad Laboratories Inc has a consensus price target of $383.86 based on the ratings of 7 analysts. The high is $550 issued by Credit Suisse on August 4, 2023. The low is $245 issued by Wells Fargo on June 9, 2025. The 3 most-recent analyst ratings were released by Wells Fargo, UBS, and Citigroup on June 9, 2025, May 2, 2025, and May 2, 2025, respectively. With an average price target of $301.67 between Wells Fargo, UBS, and Citigroup, there's an implied 30.03% upside for Bio-Rad Laboratories Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Jan
1
Feb
1
Apr
3
May
1
Jun
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.6
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Wells Fargo
UBS
Citigroup
RBC Capital
Jefferies

1calculated from analyst ratings

Analyst Ratings for Bio-Rad Laboratories

Buy NowGet Alert
06/09/2025Buy Now5.6%Wells Fargo
Brandon Couillard69%
$260 → $245MaintainsEqual-WeightGet Alert
05/02/2025Buy Now33.62%UBS
Dan Leonard55%
$355 → $310MaintainsBuyGet Alert
05/02/2025Buy Now50.86%Citigroup
Patrick Donnelly80%
$400 → $350MaintainsBuyGet Alert
05/02/2025Buy Now68.97%RBC Capital
Conor McNamara37%
$409 → $392MaintainsOutperformGet Alert
04/17/2025Buy Now16.38%Wells Fargo
Brandon Couillard69%
$320 → $270MaintainsEqual-WeightGet Alert
02/12/2025Buy Now48.71%Wells Fargo
Brandon Couillard69%
$360 → $345MaintainsEqual-WeightGet Alert
01/14/2025Buy Now107.33%RBC Capital
Conor McNamara37%
$481 → $481ReiteratesOutperform → OutperformGet Alert
12/09/2024Buy Now107.33%RBC Capital
Conor McNamara37%
$369 → $481MaintainsOutperformGet Alert
10/31/2024Buy Now93.97%Citigroup
Patrick Donnelly80%
$400 → $450MaintainsBuyGet Alert
10/31/2024Buy Now102.16%RBC Capital
Conor McNamara37%
$446 → $469MaintainsOutperformGet Alert
10/01/2024Buy Now72.41%Citigroup
Patrick Donnelly80%
$350 → $400UpgradeNeutral → BuyGet Alert
08/27/2024Buy Now46.55%Wells Fargo
Brandon Couillard69%
→ $340Initiates → Equal-WeightGet Alert
08/16/2024Buy Now72.84%RBC Capital
Conor McNamara37%
$401 → $401ReiteratesOutperform → OutperformGet Alert
08/02/2024Buy Now72.84%RBC Capital
Conor McNamara37%
$402 → $401MaintainsOutperformGet Alert
08/02/2024Buy Now50.86%Citigroup
Patrick Donnelly80%
$300 → $350MaintainsNeutralGet Alert
06/03/2024Buy Now35.78%Jefferies$440 → $315AssumesBuy → HoldGet Alert
05/08/2024Buy Now65.95%UBS
Dan Leonard55%
$420 → $385MaintainsBuyGet Alert
04/03/2024Buy Now57.33%Citigroup
Patrick Donnelly80%
$400 → $365DowngradeBuy → NeutralGet Alert
02/16/2024Buy Now81.03%UBS
Dan Leonard55%
$395 → $420MaintainsBuyGet Alert
02/16/2024Buy Now106.9%RBC Capital
Conor McNamara37%
$484 → $480MaintainsOutperformGet Alert
12/07/2023Buy Now70.26%UBS
Dan Leonard55%
→ $395Initiates → BuyGet Alert
08/07/2023Buy Now126.29%Wells Fargo
Dan Leonard55%
$550 → $525MaintainsOverweightGet Alert
08/04/2023Buy Now125.86%RBC Capital
Conor McNamara37%
$522 → $524MaintainsOutperformGet Alert
08/04/2023Buy Now137.07%Credit Suisse
Dan Leonard55%
$580 → $550MaintainsOutperformGet Alert
06/16/2023Buy Now137.07%Wells Fargo
Dan Leonard55%
→ $550Initiates → OverweightGet Alert
05/08/2023Buy Now126.29%Citigroup
Patrick Donnelly80%
$550 → $525MaintainsBuyGet Alert
05/08/2023Buy Now128.88%RBC Capital
Conor McNamara37%
$582 → $531MaintainsOutperformGet Alert
05/05/2023Buy Now150%Credit Suisse
Dan Leonard55%
$680 → $580MaintainsOutperformGet Alert
02/17/2023Buy Now149.57%RBC Capital
Conor McNamara37%
$571 → $579MaintainsOutperformGet Alert
02/17/2023Buy Now193.1%Credit Suisse
Dan Leonard55%
$640 → $680MaintainsOutperformGet Alert
12/07/2022Buy Now143.53%RBC Capital
Conor McNamara37%
→ $565Initiates → OutperformGet Alert
10/28/2022Buy Now175.86%Credit Suisse
Dan Leonard55%
$715 → $640MaintainsOutperformGet Alert
08/25/2022Buy Now208.19%Credit Suisse
Dan Leonard55%
→ $715Initiates → OutperformGet Alert
07/08/2022Buy Now201.72%Citigroup
Patrick Donnelly80%
$750 → $700MaintainsBuyGet Alert

FAQ

Q

What is the target price for Bio-Rad Laboratories (BIO) stock?

A

The latest price target for Bio-Rad Laboratories (NYSE:BIO) was reported by Wells Fargo on June 9, 2025. The analyst firm set a price target for $245.00 expecting BIO to rise to within 12 months (a possible 5.60% upside). 15 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Bio-Rad Laboratories (BIO)?

A

The latest analyst rating for Bio-Rad Laboratories (NYSE:BIO) was provided by Wells Fargo, and Bio-Rad Laboratories maintained their equal-weight rating.

Q

When was the last upgrade for Bio-Rad Laboratories (BIO)?

A

The last upgrade for Bio-Rad Laboratories Inc happened on October 1, 2024 when Citigroup raised their price target to $400. Citigroup previously had a neutral for Bio-Rad Laboratories Inc.

Q

When was the last downgrade for Bio-Rad Laboratories (BIO)?

A

The last downgrade for Bio-Rad Laboratories Inc happened on April 3, 2024 when Citigroup changed their price target from $400 to $365 for Bio-Rad Laboratories Inc.

Q

When is the next analyst rating going to be posted or updated for Bio-Rad Laboratories (BIO)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Bio-Rad Laboratories, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Bio-Rad Laboratories was filed on June 9, 2025 so you should expect the next rating to be made available sometime around June 9, 2026.

Q

Is the Analyst Rating Bio-Rad Laboratories (BIO) correct?

A

While ratings are subjective and will change, the latest Bio-Rad Laboratories (BIO) rating was a maintained with a price target of $260.00 to $245.00. The current price Bio-Rad Laboratories (BIO) is trading at is $232.00, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch